Jiuzhitang Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiuzhitang Company Limited with three other
companies in this sector in CHINA :
Anhui Fengyuan Pharmaceutical
sales of 3.24 billion Chinese Renmimbi [US$457.93 million]
of which 51%
was Medicine Manufacturing),
Jilin Aodong Medicine Industry (Group) Co., Ltd.
(3.09 billion Chinese Renmimbi [US$436.73 million]
of which 94%
was Pharmaceutical Manufacturing), and
Chengdu Kanghong Pharmaceutical Group Co Ltd
(3.26 billion Chinese Renmimbi [US$460.63 million]
of which 100%
was Pharmaceutical Manufacturing).
During the year ended December of 2019, sales at
Jiuzhitang Company Limited were 3.18 billion Chinese Renmimbi (US$450.24 million).
a very small
increase of 2.0%
versus 2018, when the company's sales were 3.12 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2017, when Jiuzhitang Company Limited
reported sales of 3.84 billion Chinese Renmimbi.
Sales of Pharmacuetical Commerce saw an increase
that was more than double the company's growth rate: sales were up
14.7% in 2019, from
798.28 million Chinese Renmimbi to 915.29 million Chinese Renmimbi.
Not all segments of Jiuzhitang Company Limited experienced an increase in sales in 2019:
sales of Pharmacuetical Industry fell 5.8% to 2.80 billion Chinese Renmimbi.
Jiuzhitang Company Limited also experienced decreases in sales in
Other Operations (down 1.2% to 19.48 million Chinese Renmimbi)